Read: AION Labs, In Continued Partnership with BioMed X, Launches First 2024 Global Call for Applications: AI/ML Platform for Targeting RNA with Small Molecules AION Labs, In Continued Partnership with BioMed X, Launches First 2024 Global Call for Applications: AI/ML Platform for Targeting RNA with Small Molecules Feb 20, 2024
Read: New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine Feb 6, 2024
Read: BioMed X and Ono Pharmaceutical Launch New Collaboration in Cancer Research BioMed X and Ono Pharmaceutical Launch New Collaboration in Cancer Research Dec 19, 2023
Read: BioMed X Launches a New Call for Application in Autoimmune Disease Research BioMed X Launches a New Call for Application in Autoimmune Disease Research Nov 7, 2023
Read: BioMed X and AbbVie Start New Research Project in the USA BioMed X and AbbVie Start New Research Project in the USA Oct 31, 2023
Read: BioMed X Institute Starts Its First Research Project with Sanofi on Artificial Intelligence for Drug Development BioMed X Institute Starts Its First Research Project with Sanofi on Artificial Intelligence for Drug Development Jun 29, 2023
Read: AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery May 25, 2023
Read: BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus Apr 27, 2023
Read: BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies Apr 4, 2023
Read: BioMed X Launches New T Cell Immunology Discovery Platform BioMed X Launches New T Cell Immunology Discovery Platform Feb 14, 2023
Read: BioMed X and AbbVie Extend Research Collaboration in the US BioMed X and AbbVie Extend Research Collaboration in the US Jan 16, 2023
Read: BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development Oct 24, 2022
Read: BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology Aug 1, 2022
Read: AION Labs, in Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations AION Labs, in Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations Jun 29, 2022
Read: BioMed X Institute Launches Ukraine Refugee Funding Program BioMed X Institute Launches Ukraine Refugee Funding Program May 18, 2022
Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology Mar 15, 2022
Read: BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development Mar 1, 2022
Read: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies Feb 14, 2022
Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology Feb 1, 2022
Read: AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates Dec 13, 2021
Read: BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany Nov 2, 2021
In the Media In the Media Media is constantly reporting on BioMed X and its work. Read our current media coverage. Read more
Past Lunch Talks Past Lunch Talks In the “Lunch Talk Series“, group leaders from BioMed X and the Postdoc Network of the German Cancer Research Center (DKFZ) invite renowned life scientists to share their research and foster scientific exchanges. Read more
